NAWGEN, LLC
Biotech · Defunct
Optimized single guide RNA (sgRNA) design software and methods for CRISPR/Cas9 genome editing
- Grants
- $1.1M
- 4 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20142015201620172018
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · New Assays for Expression Profiling of MicroRNAs | $224,951 | |
| Federal grant | Department of Health and Human Services · Phase I · Rational design of small interfering RNA for genome-wide target knockdown | $347,147 | |
| Federal grant | Department of Health and Human Services · Phase I · Rational design of small interfering RNA for genome-wide target knockdown | $349,932 | |
| Federal grant | Department of Health and Human Services · Phase I · Improving the Design of CRISPR/Cas9 Knockout Assays | $223,896 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1386 | Atrapos Therapeutics, LLC | — | — |
| 1387 | Mycosynthetix, Inc. | — | — |
| 1388 | SELSYM BIOTECH INC | — | — |
| 1389 | NAWGEN, LLC | — | — |
| 1390 | VIVREON BIOSCIENCES LLC | — | — |
| 1391 | GROVE BIOPHARMA, INC. | — | — |
| 1392 | CYNVEC, LLC | — | $500K |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.